STRS OHIO - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 184 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.39 and the average weighting 0.0%.

Quarter-by-quarter ownership
STRS OHIO ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$36
-54.4%
61,3000.0%0.00%
Q2 2023$79
-75.4%
61,300
-66.7%
0.00%
Q1 2023$321
+67.2%
183,900
+200.0%
0.00%
-100.0%
Q4 2022$192
-99.9%
61,3000.0%0.00%0.0%
Q3 2022$300,000
+18.6%
61,3000.0%0.00%0.0%
Q2 2022$253,000
-24.5%
61,300
+6.1%
0.00%0.0%
Q1 2022$335,000
-22.6%
57,8000.0%0.00%
-50.0%
Q4 2021$433,000
-16.7%
57,8000.0%0.00%0.0%
Q3 2021$520,000
+6.6%
57,800
+41.7%
0.00%0.0%
Q2 2021$488,000
+8.0%
40,800
+13.0%
0.00%0.0%
Q1 2021$452,000
-11.4%
36,100
+10.4%
0.00%0.0%
Q4 2020$510,000
+28.1%
32,700
+39.1%
0.00%0.0%
Q3 2018$398,000
-23.2%
23,500
-35.6%
0.00%0.0%
Q2 2018$518,000
-17.8%
36,500
+9.9%
0.00%
-33.3%
Q1 2018$630,000
+27.8%
33,200
+10.3%
0.00%
+50.0%
Q4 2017$493,000
+9.3%
30,1000.0%0.00%0.0%
Q3 2017$451,000
+241.7%
30,100
+146.7%
0.00%
Q3 2014$132,000
+120.0%
12,200
+212.8%
0.00%
Q2 2014$60,000
-15.5%
3,9000.0%0.00%
Q1 2014$71,000
-81.2%
3,900
-89.2%
0.00%
-100.0%
Q3 2013$378,000
+34.0%
36,1000.0%0.00%
+100.0%
Q2 2013$282,00036,1000.00%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Golden State Equity Partners 154,360$897,0000.45%
Rhenman & Partners Asset Management AB 761,429$4,424,0000.44%
Lombard Odier Asset Management (Switzerland) SA 860,702$5,001,0000.39%
WASATCH ADVISORS LP 10,576,997$61,452,0000.30%
Rokos Capital Management LLP 977,663$5,861,0000.27%
KLK CAPITAL MANAGEMENT LLC 44,323$258,0000.26%
Long Focus Capital Management, LLC 340,000$1,975,0000.25%
Vanguard Capital Wealth Advisors 33,380$193,0000.14%
Fort Sheridan Advisors LLC 73,978$430,0000.13%
Delphia (USA) Inc. 20,983$122,0000.09%
View complete list of SANGAMO THERAPEUTICS INC shareholders